- Director, Breast Cancer Program, UH Seidman Cancer Center
- Associate Professor, CWRU School of Medicine
Alberto Montero, MD, MBA, CPHQ, is clinical director of the Breast Cancer Medical Oncology Program at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University School of Medicine. He is board certified in medical oncology by the American Board of Internal Medicine.
Dr. Montero has been in academic practice for over 13 years and has demonstrated a strong track record of clinical research in breast cancer. Prior to joining the UH Seidman Cancer Center team, Dr. Montero spent seven years at the Cleveland Clinic, where he served as a staff physician in the hematology and oncology department, as well as chief quality improvement officer and patient experience officer. Before that, Dr. Montero was on staff at University of Miami Sylvester Cancer Center as Breast Cancer Site Disease Group co-leader, and at the Medical University of South Carolina Division of Hematology/Oncology.
Dr. Montero graduated summa cum laude with a Bachelor of Arts degree at University of Texas at Austin and earned his medical degree from University of Texas, Galveston. He also earned his MBA at University of Miami School of Business. He completed his internal medicine residency training at University of Texas Health Science Center at Houston and his hematology-oncology fellowship at University of Texas M.D. Anderson Cancer Center.
Dr. Montero is very active in breast cancer research and has served as Principal Investigator in numerous clinical trials. He has over 100 peer-reviewed publications. He has served on numerous committees and editorial boards, including serving as associate editor for Breast Cancer Research & Treatment, and recently has served as a reviewer and study chair for the Department of Defense Breast Cancer Research Program (BCRP). He is a member of several professional societies, including American Society of Clinical Oncology, American Association of Cancer Research, and Society for Immunotherapy of Cancer.
Honors and awards Dr. Montero has received include membership in the Beta Gamma Sigma Honor Society, the Papanicolaou Corps for Cancer Research Pap Corps Fellowship, and the ASCO/AACR Methods in Cancer Research Workshop and School of Breast Oncology Course travel awards.
- ER-Positive Breast Cancer
- HER2-Positive Breast Cancer
- Metastatic Breast Cancer
- Triple-Negative Breast Cancer
- Medical Oncology - American Board of Internal Medicine
Fellowship | Hematology/Oncology
Hematology/Oncology - University Of Texas MD Anderson Cancer Center (2002 - 2005)
Residency | Internal Medicine
Internal Medicine - University Of Texas Health Science Center At Houston (1999 - 2002)
University Of Miami (2013)
University Of Texas Medical Branch Medical School, Galveston (1999)
University Of Texas At Austin (1994)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alberto Montero did not disclose any Outside Relationships with Industry.